Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-008670
Filing Date
2021-09-08
Accepted
2021-09-08 16:28:47
Documents
2
Period of Report
2021-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2274
2 POWER OF ATTORNEY ex24reeve.txt EX-24 4488
  Complete submission text file 0001179110-21-008670.txt   8103
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451
Business Address
Reeve Emma (Reporting) CIK: 0001680329 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37687 | Film No.: 211242409